Ergomed at the World Orphan Drug Congress 2013

In Orphan Drug Congress by Cameron

Hear about ERGOMED’s experience at the World Orphan Drug Congress and why they decided to sponsor the event this year.

ERGOMED is a clinical development company providing consultancy and full clinical trial related services. ERGOMED can also invest in  co-development partnerships thus sharing the risks and rewards of clinical development.

The annual World Orphan Drug Congress Europe is the region’s largest event dedicated to dedicated to scientific, commercialisation and business development: an exhibition, a strategic keynote conference and real life case studies.